跳至主要内容
临床试验/NCT07785986
NCT07785986已完成不适用

Comparative Efficacy of Oral Curcumin Supplementation Versus Ibuprofen on Exercise-Induced Muscle Damage, Inflammation, Oxidative Stress, and Sports Performance in Physically Active Women: A Randomized Double-Blind Placebo-Controlled Trial

University of Valladolid1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年1月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Exercise-induced muscle damage

研究概览

简要总结

xercise-induced muscle damage (EIMD) is a common consequence of unaccustomed or high-intensity exercise and is characterized by muscle soreness, impaired physical performance, inflammation, oxidative stress, and increased circulating biomarkers of muscle damage. Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are frequently used to alleviate these symptoms, although their repeated use may be associated with adverse effects. Curcumin, a natural polyphenol with antioxidant and anti-inflammatory properties, has emerged as a potential nutritional strategy to support post-exercise recovery.

This randomized, double-blind, placebo-controlled trial aims to compare the effects of oral curcumin supplementation and ibuprofen administration on exercise-induced muscle damage in physically active women. The study evaluates clinical outcomes, physical performance, biomarkers of muscle damage, inflammation, oxidative stress, and other health-related biomarkers to determine whether curcumin may represent a safe and effective nutritional alternative for promoting recovery after eccentric exercise.

详细描述

Exercise-induced muscle damage (EIMD) following eccentric exercise is characterized by structural disruption of skeletal muscle fibers accompanied by transient inflammation, oxidative stress, delayed-onset muscle soreness, and impaired physical performance. Although these responses are considered part of the normal adaptive process, excessive muscle damage may delay recovery and impair subsequent training or competition.

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used by athletes to reduce post-exercise pain and inflammation. However, repeated NSAID use has been associated with gastrointestinal, renal, and cardiovascular adverse effects, highlighting the need for safe nutritional alternatives capable of supporting recovery without interfering with physiological adaptation.

Curcumin, the principal bioactive polyphenol derived from Curcuma longa, exhibits antioxidant, anti-inflammatory, and cytoprotective properties through modulation of multiple molecular pathways involved in redox homeostasis and inflammatory signaling. Experimental and clinical studies suggest that curcumin may attenuate exercise-induced muscle damage by reducing oxidative stress, inflammatory responses, and muscle soreness, although evidence remains inconsistent and direct comparisons with NSAIDs are scarce.

The objective of this randomized, double-blind, placebo-controlled trial is to compare the efficacy of oral curcumin supplementation with ibuprofen and placebo in physically active women following eccentric exercise. The study evaluates clinical recovery, physical performance, biomarkers of muscle damage, inflammatory and oxidative stress biomarkers, and additional health-related biomarkers in order to characterize the physiological effects of curcumin supplementation and determine its potential role as a nutritional strategy for exercise recovery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

Participants, investigators responsible for data collection, and outcome assessors remained blinded to treatment allocation throughout the study. Curcumin, ibuprofen, and placebo capsules were identical in appearance, packaging, and administration schedule. Treatment allocation codes were concealed until completion of data collection and statistical analysis.

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy physically active women. Age within the predefined study range. Regular participation in physical activity for at least 6 months before enrollment.
  • Ability to perform the eccentric exercise protocol. Written informed consent provided before participation.

排除标准

  • Current musculoskeletal injury or pain affecting exercise performance. History of cardiovascular, metabolic, neurological, renal, hepatic, or inflammatory disease.
  • Pregnancy or breastfeeding. Current use of anti-inflammatory drugs, antioxidant supplements, or other nutritional supplements that could interfere with study outcomes.
  • Known allergy or intolerance to curcumin, turmeric, ibuprofen, or study ingredients.
  • Smoking or excessive alcohol consumption. Participation in another clinical trial during the study period. Any condition considered by the investigators to compromise participant safety or protocol compliance.

研究组 & 干预措施

Placebo

Placebo Comparator

Participants received placebo capsules identical in appearance to the active interventions according to the study protocol before and following the eccentric exercise protocol. Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.

干预措施: Placebo (Other)

Curcumin

Experimental

Participants received oral curcumin supplementation according to the study protocol before and following the eccentric exercise protocol. Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.

干预措施: Curcumin (Dietary Supplement)

Ibuprofen

Active Comparator

articipants received oral ibuprofen according to the study protocol before and following the eccentric exercise protocol. Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.

干预措施: Ibuprofen (Drug)

结局指标

主要结局

Exercise-induced muscle damage

时间窗: Baseline and during the 72-hour recovery period following eccentric exercise.

Exercise-induced muscle damage assessed using clinical outcomes and biochemical biomarkers following eccentric exercise to compare the effects of oral curcumin supplementation, ibuprofen, and placebo in physically active women.

次要结局

  • Creatine kinase (CK)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Lactate dehydrogenase (LDH)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Aspartate aminotransferase (AST)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Alanine aminotransferase (ALT)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Alkaline phosphatase (ALP)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Interleukin-6 (IL-6)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • C-reactive protein (CRP)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Malondialdehyde (MDA)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Superoxide dismutase (SOD)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Catalase (CAT)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Delayed-onset muscle soreness (DOMS)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Countermovement jump (CMJ)(Baseline and during the 48-hour recovery period following eccentric exercise.)
  • Thigh circumference(Baseline and during the 48-hour recovery period following eccentric exercise.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Diego Fernández Lázaro

Professor of Histology and Researcher, Neurobiology Research Group, University of Valladolid

University of Valladolid

研究点 (1)

Loading locations...

相似试验